BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25287362)

  • 1. Up-regulation of S100A16 expression promotes epithelial-mesenchymal transition via Notch1 pathway in breast cancer.
    Zhou W; Pan H; Xia T; Xue J; Cheng L; Fan P; Zhang Y; Zhu W; Xue Y; Liu X; Ding Q; Liu Y; Wang S
    J Biomed Sci; 2014 Oct; 21(1):97. PubMed ID: 25287362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of calcium binding protein S100A16 with myosin-9 promotes cytoskeleton reorganization in renal tubulointerstitial fibrosis.
    Sun H; Zhao A; Li M; Dong H; Sun Y; Zhang X; Zhu Q; Bukhari AA; Cao C; Su D; Liu Y; Liang X
    Cell Death Dis; 2020 Feb; 11(2):146. PubMed ID: 32094322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch1 induces epithelial-mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role.
    Zhang X; Zhao X; Shao S; Zuo X; Ning Q; Luo M; Gu S; Zhao X
    Int J Oncol; 2015 Mar; 46(3):1141-8. PubMed ID: 25544568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.
    Tanaka M; Ichikawa-Tomikawa N; Shishito N; Nishiura K; Miura T; Hozumi A; Chiba H; Yoshida S; Ohtake T; Sugino T
    BMC Cancer; 2015 Feb; 15():53. PubMed ID: 25884418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A16 suppresses the proliferation, migration and invasion of colorectal cancer cells in part via the JNK/p38 MAPK pathway.
    Ou S; Liao Y; Shi J; Tang J; Ye Y; Wu F; Wang W; Fei J; Xie F; Bai L
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Update on S100A16 in Human Cancer.
    Basnet S; Vallenari EM; Maharjan U; Sharma S; Schreurs O; Sapkota D
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-6884-5p Regulates the Proliferation, Invasion, and EMT of Gastric Cancer Cells by Directly Targeting S100A16.
    Lv H; Hou H; Lei H; Nie C; Chen B; Bie L; Han L; Chen X
    Oncol Res; 2020 May; 28(3):225-236. PubMed ID: 31796150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.
    Zhu W; Xue Y; Liang C; Zhang R; Zhang Z; Li H; Su D; Liang X; Zhang Y; Huang Q; Liu M; Li L; Li D; Zhao AZ; Liu Y
    Tumour Biol; 2016 Sep; 37(9):12241-12250. PubMed ID: 27240591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
    Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
    J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of the Notch1-Snail/Slug-epithelial to mesenchymal transition axis for lymph node metastasis in infiltrating ductal carcinoma.
    Cao YW; Wan GX; Sun JP; Cui XB; Hu JM; Liang WH; Zheng YQ; Li WQ; Li F
    Kaohsiung J Med Sci; 2015 Feb; 31(2):70-6. PubMed ID: 25645984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells.
    Shan S; Lv Q; Zhao Y; Liu C; Sun Y; Xi K; Xiao J; Li C
    Int J Clin Exp Pathol; 2015; 8(10):12357-67. PubMed ID: 26722422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
    Song R; Zhang J; Huang J; Hai T
    Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.
    Tsubaki M; Komai M; Fujimoto S; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S
    J Exp Clin Cancer Res; 2013 Sep; 32(1):62. PubMed ID: 24011086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ROR2 promotes the epithelial-mesenchymal transition by regulating MAPK/p38 signaling pathway in breast cancer.
    Xu J; Shi J; Tang W; Jiang P; Guo M; Zhang B; Ma G
    J Cell Biochem; 2020 Oct; 121(10):4142-4153. PubMed ID: 32048761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of SDF-1 activates the NF-κB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells.
    Kong L; Guo S; Liu C; Zhao Y; Feng C; Liu Y; Wang T; Li C
    Int J Oncol; 2016 Mar; 48(3):1085-94. PubMed ID: 26782945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NR2F2 plays a major role in insulin-induced epithelial-mesenchymal transition in breast cancer cells.
    Xia B; Hou L; Kang H; Chang W; Liu Y; Zhang Y; Ding Y
    BMC Cancer; 2020 Jul; 20(1):626. PubMed ID: 32631390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.